Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation

Blood

Volumn 93, Issue 6, 1999, Pages 1969-1979

  Yabkowitz, Rachel ^a,b   Meyer, Susanne ^a   Black, Tabitha ^a   Elliott, Gary ^a   Merewether, Lee Anne ^a   Yamane, Harvey K ^a  

^a AMGEN INC   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL SURFACE RECEPTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; METALLOPROTEINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

EID: 0033560025     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.6.1969.406k14_1969_1979     Document Type: Article

References (42)

1. Brindle NPJ: Growth factors in endothelial regeneration. Cardiovasc Res 27:1162, 1993
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27, 1995
3. Van der Geer P, Hunter T, Lindberg R: Receptor protein tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251, 1994
4. Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895, 1995
5. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18:4, 1997
6. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115, 1992
7. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353, 1996
8. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn L: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56:1615, 1996
9. Batard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Buhring H-J, Monier M-N, Kukk E, Partanen J, Matikainen MT, Alitalo R, Hatzfeld J, Alitalo K: The tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 87:2212, 1996
10. Armstrong E, Korhonen J, Silvennoinen O, Cleveland JL, Lieberman MA, Alitalo R: Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 7:1585, 1993
11. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase Tie is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884, 1995
12. Kaipaninen A, Vlaykova T, Jatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K: Enhanced expression of the tie receptor kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 54:6571, 1994
13. Hatva E, Kaipainen A, Mentula P, Jääskeläinen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368, 1995
14. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80:2548, 1992
15. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell 87:1161, 1996
16. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 87:1171, 1996
17. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70, 1995
18. Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA. Marchuk DA, Warman ML, Cantley LC, Muliken JB, Olsen BR: Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase Tie2. Cell 87:1181, 1996
19. Lin P, Buxton JA, Acheson A, Radziejewski C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst MW, George SE, Peters KG: Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie-2. Proc Natl Acad Sci USA 95:8829, 1998
20. Yabkowitz R, Meyer S, Yanagihara D, Brankow D, Staley T, Elliott G, Hu S, Ratzkin B: Regulation of tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble tie. Blood 90:706, 1997
21. Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, Anderson L, Pyle SM, Moreland J, Meyers MA, Kohno T, Lyons D, Lichenstein HS: Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 272:24588, 1997
22. Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Miura Y: Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 87:4552, 1996
23. Schneider C, Newman RA, Sutherland DR, Asser U, Greaves MF: A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem 257:10766, 1982
24. Vamum BC, Young C, Elliott G, Garcia A, Hartley TD, Fridell YW, Hunt RW, Trail G, Clogston C, Toso RJ, Yanagihara D, Bennett L, Sylber M, Merewether LA, Tseng A, Escobar E, Liu ET, Yamane HK: Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373:623, 1995
25. Netzel-Arnett S, Sang Q-X, Moore WGI, Navre M, Birkedal-Hansen H, Van Wart HE: Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 32:6427, 1993
26. Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM: A metalloprotease inhibitor blocks shedding of the 1L-6 receptor and the p60 TNF receptor. J Immunol 155:5198, 1995
27. Moss ML, Jin SC, Milla ME, Burkhart W, Carter HL, Chen W-J, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Panel G, Rocque W, Overton L, Schoenen F, Seaton T, Su J-L, Warner J, Willard D, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733, 1997
28. Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL, Pulvino T, Wahl RC: Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1′ group. J Med Chem 38:2570, 1995
29. Massague J, Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 62:515, 1993
30. Rose-John S, Heinrich PC: Soluble receptors for cytokines and growth factors: Generation and biological function. Biochem J 300:281, 1994
31. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J: Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 271:11376, 1996
32. Orlando S, Matteucci C, Fadlon EJ, Buurman WA, Bardella MT, Colotta F, Introna M, Mantovani A: TNF-α, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 158:3861, 1997
33. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 277:55, 1997
34. Ehlers MR, Schwager SL, Scholle RR, Mangi GA, Brandt WF, Riordan JF: Proteolytic release of membrane-bound angiotensin-converting enzyme: Role of the juxtamembrane stalk sequence. Biochemistry 35:9549, 1996
35. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drumond AH, Galloway WA, Gilbert R, Gordon JL. Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W. Wells G, Wood LM, Woolley K: Processing of tumour necrosis factor-α by metalloproteinases. Nature 370:555, 1994
36. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawama K, Kronheim SR, Petersen M, Gerhart M, Kozlosky CJ, March CJ, Black RA: Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218, 1994
37. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson WF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Hohnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729, 1997
38. Blobel CP: Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNFα and notch. Cell 90:589, 1997
39. Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee M-E, Haber E: Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98:490, 1996
40. Conover CA: Regulation and physiological role of insulin-like growth factor binding proteins. Endocrine J 43:S43, 1996
41. Fernandez-Botran R: Soluble cytokine receptors: Their role in immunoregulation. FASEB J 5:2567, 1991
42. Aderka D: The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231, 1996